$SPHS News Sophiris Bio's topsalysin fails to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$SPHS News

Sophiris Bio's topsalysin fails to demonstrate efficacy for BPH-associated urinary tract symptoms 8:33 a.m. Today - Seeking Alpha
Sophiris Bio - Upcoming Catalysts Present Very Attractive Upside 9:30 a.m. Nov. 24, 2014 - Seeking Alpha
3 Stocks Pushing The Drugs Industry Lower 3:32 p.m. Nov. 13, 2014 - TheStreet.com
10-Q: SOPHIRIS BIO INC. 4:47 p.m. Nov. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Strength Seen in Sophiris Bio (SPHS): Stock Soars 25% - Tale of the Tape 9:46 a.m. Nov. 5, 2014 - Zacks.com
3 Drugs Stocks Nudging The Industry Higher 5:50 p.m. Oct. 6, 2014 - TheStreet.com
10-Q: SOPHIRIS BIO INC. 3:39 p.m. May 13, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: SOPHIRIS BIO INC. 3:25 p.m. March 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Sophiris Bio: Recent Price Action Offers An Attractive Entry Point 10:42 a.m. Dec. 31, 2013 - Seeking Alpha
Sophiris Bio: Under The Radar Despite 100% Upside 12:38 p.m. Oct. 31, 2013 - Seeking Alpha
From The Land of What If - Smart Proteins and Debt Collectors 9:03 p.m. Sept. 28, 2013 - GuruFocus.com
Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low 12:52 p.m. Sept. 3, 2013 - GuruFocus.com

Sophiris Bio Reports Administrative Interim Analysis for the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia 8:02 a.m. Today - BusinessWire - BZX
Sophiris Bio to Present at the 26th Annual Piper Jaffray Healthcare Conference 8:02 a.m. Nov. 25, 2014 - BusinessWire - BZX
Sophiris Bio Reports Third Quarter Financial Results 4:07 p.m. Nov. 12, 2014 - BusinessWire - BZX
Sophiris Bio to Present at the Stifel 2014 Healthcare Conference 4:05 p.m. Nov. 7, 2014 - BusinessWire - BZX
Sophiris Bio to Present at the 13th Annual BIO Investor Forum 7:01 a.m. Sept. 30, 2014 - BusinessWire - BZX
Sophiris Bio Reports Completion of Enrollment in the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia 7:01 a.m. Sept. 2, 2014 - BusinessWire - BZX
Sophiris Bio Reports Second Quarter Financial Results and Key Operational and Financial Highlights 3:08 p.m. Aug. 7, 2014 - BusinessWire - BZX
Sophiris Bio to Present at the Jefferies 2014 Global Healthcare Conference 3:06 p.m. May 22, 2014 - BusinessWire - BZX
Sophiris Enters into Common Stock Purchase Agreement with Aspire Capital to Support Proof of Concept Study of PRX302 in Prostate Cancer 7:02 a.m. May 19, 2014 - BusinessWire - BZX
Sophiris Bio Reports First Quarter Financial Results 3:06 p.m. May 13, 2014 - BusinessWire - BZX
Sophiris Bio to Present at the 13th Annual Needham Healthcare Conference 3:06 p.m. March 25, 2014 - BusinessWire - BZX
Sophiris Adds Gerald T. Proehl to its Board of Directors 7:01 a.m. March 20, 2014 - BusinessWire - BZX
Sophiris Bio Reports Fourth Quarter and Full Year 2013 Financial Results and Key Operational Highlights 3:16 p.m. March 13, 2014 - BusinessWire - BZX
Sophiris Bio to Present at the Cowen and Company 34th Annual Health Care Conference 8:03 a.m. Feb. 26, 2014 - BusinessWire - BZX
Sophiris Bio to Present at the 2014 Leerink Global Healthcare Conference 4:40 p.m. Feb. 3, 2014 - BusinessWire - BZX
Sophiris Bio Reports Third Quarter Financial Results and Recent Key Operational Highlights 4:05 p.m. Nov. 12, 2013 - BusinessWire
Sophiris Bio Applies for Voluntary Delisting from TSX 4:05 p.m. Nov. 5, 2013 - BusinessWire
Sophiris Announces First Patients Dosed in the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia 3:05 p.m. Oct. 28, 2013 - BusinessWire
RDInvesting Provides Investors with Free In-Depth Equity Reports on AVNR, SGNT, SPHS and WLK 7:51 a.m. Sept. 12, 2013 - ACCESSWIRE
Sophiris Bio to Present at the Stifel Healthcare Conference 4:00 p.m. Sept. 5, 2013 - PR Newswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Humberto Quintanar Strengthens McKinley Irvin's Seattle Team

Updated Category News Views 46

Humberto Quintanar Makes His Move In a world where legal battles can shake lives to the core, McKinley Irvin is throwing another heavyweight into the ring. They’ve just pulled in Humberto Quintanar, a guy who knows his way around a courtroom like a cabbie knows a city's backstreets. This isn't just another seat-fillin' lawyer; Quintanar packs years of experience as a...

Continue Reading
Approved Oil Secures Long-Term NYC Fuel Terminal Deal

Updated Category News Views 94

Approved Oil Locks in Future with Sunoco Deal Amidst the contraction of New York City's fuel terminal landscape, securing a consistent lifeline to crucial infrastructure feels like striking gold. Approved Oil just locked down an agreement with Sunoco for a new terminal location that'll last deep into the 2040s, and it's about more than just securing a spot on the...

Continue Reading
Columbia Distributing Expands to Alaska: A Growth Move

Updated Category News Views 33

Alaska's Entry: Columbia's New Frontier When Columbia Distributing dives into a new territory, you know they're serious about growth. This latest move sees them planting their flag in Alaska, finally completing a strategic vision that's been brewing for a while. Four-State Strategy Comes to Fruition The transaction with Republic National Distributing Company (RNDC) is no...

Continue Reading
Gildan's Troubling Legal Struggles: Investor Action Alert

Updated Category News Views 60

Gildan's Bumpy Ride: Legal Woes Unfold Well, folks, seems like Gildan Activewear Inc. (NYSE:GIL) is in for a bumpy ride, and not the kind that makes you feel alive, I tell ya. They've been slapped with a class action lawsuit, and the news ain't pretty. Accusations are flying hot about how they've been playing fast and loose with their financials. The Allegations: Channel...

Continue Reading
DropGenie Nets $5M to Boost Functional Biology Reach

Updated Category News Views 109

DropGenie Scores Big with Fresh Financing Boost Out of the Montreal wilderness, DropGenie is charging forward with a fresh $5 million injection in Seed+ financing. This isn't just loose change; it's a ticket to accelerating their mission of advancing functional biology platforms and beefing up data partnerships. You know, the kind of partnerships that even the suits in...

Continue Reading
Skechers Facing Class Action: Investors Urged to Act

Updated Category News Views 0

Skechers Under Fire: Fraud Allegations Surface Alright, if you've been around the stock block a while, you know these stories can often read like a suspense novel. Plot twist: Skechers U.S.A., Inc. (formerly NYSE: SKX) is now facing some serious accusations. There's a class action lawsuit claiming that some shady dealings went down during the company's $9.4 billion...

Continue Reading
Cumberland Pharmaceuticals Eyes NDA for Ifetroban in DMD

Updated Category News Views 0

Rolling the Dice with Ifetroban There's a buzz in the air around Cumberland Pharmaceuticals as they gear up to tackle one of medicine's stubborn giants, Duchenne muscular dystrophy (DMD). They plan to file a New Drug Application (NDA) with the FDA for ifetroban, aiming to treat the cardiomyopathy plaguing many DMD sufferers. Folks who’ve watched Cumberland (NASDAQ:CPIX)...

Continue Reading
Ernesta Expands Southeast Reach with Atlanta Showroom

Updated Category News Views 85

Ernesta's Southeast Play: The Atlanta Showroom Here's something to turn heads in the world of custom home design—Ernesta has just set up shop in Atlanta, a move that speaks volumes about their ambitions in the Southeast market. This isn't just about selling a few more rugs; it's a calculated step into a region ripe with design potential and a hunger for bespoke home...

Continue Reading
Gildan Activewear Faces Major Class Action Lawsuit

Updated Category News Views 126

Investors Turn Against Gildan Activewear Ever see a freight train barreling down the track? That's what it feels like when a class action lawsuit rears its head against a behemoth like Gildan Activewear Inc. (NYSE: GIL). After years of allegedly pulling the wool over investors' eyes, those same investors are now being called to muster—their chance to lead a charge of...

Continue Reading
Bertram Capital Backs MCE's Expansive Growth Vision

Updated Category News Views 92

A Strategic Move for Bertram Capital Right on the heels of seasoned market moves, Bertram Capital has thrown its support behind Motion & Control Enterprises (MCE). This isn't just another portfolio addition; it's a calculated step into the complex world of industrial distribution, partnering with a company renowned for its prowess in engineered solutions. If you've ever...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Opportunities at the 2026 China Clean Expo

Updated Category News Views 158

Welcome to the China Clean Expo 2026 The 27th China Clean Expo (CCE) is set to take place from March 31 to April 3, 2026, at the Shanghai New International Expo Center. This event, organized by IM Sinoexpo with support from notable associations, including ISSA, promises to be a hub for industry leaders, innovators, and solution providers in the cleaning sector. The...

Continue Reading
Magellan Health and Calm Health Collaboration Enhances Support

Updated Category News Views 372

Magellan Health Partners with Calm Health Magellan Health, Inc. is excited to announce a new partnership with Calm Health, aimed at providing improved mental health support for its members. This collaboration is designed to streamline the process for individuals seeking help, ensuring they receive the necessary resources in a timely manner. Understanding the Importance of...

Continue Reading
Celebrating the Visionaries: 2025 Franklin Institute Laureates

Updated Category News Views 3874

Honoring Global Innovators Across Science and Business The Franklin Institute is set to celebrate the exceptional contributions of its 2025 Franklin Institute Laureates. This illustrious occasion recognizes pioneers who have made significant advancements in science, technology, and business leadership. Among the nine distinguished honorees are trailblazers like Muyinatu...

Continue Reading
Origin Investments Launches Innovative 1031 Exchange Program

Updated Category News Views 267

Origin Investments Enters the 1031 Exchange Market Origin Investments has marked a significant milestone by completing its first acquisition under the newly established Origin Exchange program, which focuses on Delaware Statutory Trust (DST) investments. The company has acquired The Starling, a modern multifamily community featuring 300 recently developed units,...

Continue Reading
Tenaris Sees Growth Amid Challenges in Q2 2025 Financials

Updated Category News Views 263

Tenaris Reports Second Quarter Financial Results for 2025 Tenaris S.A. (NYSE: TS, BMV: TS.MX, Milan: TEN) has released its financial results for the second quarter of 2025, demonstrating resilience in a fluctuating market. Compared to the same period last year, there have been notable changes in performance metrics, illustrating both growth opportunities and challenges...

Continue Reading